World's Best Scientists 2026 revealed!
Journal of Clinical Oncology
H-index 193

Journal of Clinical Oncology

0732-183X

Published by: American Society of Clinical Oncology

https://ascopubs.org/journal/jco/

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 5 3450 14775 191

Additional Metrics

Number of Best Scientists*: 5562
Documents by Best Scientists*: 16924
Top 100 Ranked Scientists*: 176
SCIMAGO H-index: 646
SCIMAGO SJR: 11.205
Impact Factor: 41.9

Overview

Top Research Topics at Journal of Clinical Oncology?

Journal of Clinical Oncology aims to foster the development of research in Internal medicine, Oncology, Cancer, Surgery and Cancer research. Journal of Clinical Oncology explores Internal medicine concepts, specifically Chemotherapy, Breast cancer and Colorectal cancer but expands to research in In patient. Cisplatin is a focus of the presented Chemotherapy works and it dives deep in Cisplatin.

The Breast cancer study tackled is a key component of adjacent topics in the area of Gynecology. Topics in Oncology explored in it were investigated in conjunction with research in Clinical trial, Phases of clinical research, Pathology and Prostate cancer. The studies in Cancer featured incorporate elements of Family medicine and Intensive care medicine.

The journal focuses on Surgery as well as the interrelated topic of Urology. Non small cell is part of Lung cancer studies tackled in the journal.

  • Internal medicine (53.35%)
  • Oncology (43.67%)
  • Cancer (16.58%)

What are the most cited papers published in the journal?

  • Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. (4774 citations)
  • The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. (4389 citations)
  • American society of clinical oncology/college of american pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer (3934 citations)

Research areas of the most cited articles at Journal of Clinical Oncology:

The published papers facilitate discussions on Internal medicine, Surgery, Oncology, Chemotherapy and Cancer. While Internal medicine is the focus of the most cited publications, it also provides insights into the studies of Gastroenterology and Pathology. The most cited papers focus on Surgery but the discussions also offer insight into other areas such as Carcinoma and Urology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Cancer
  • Disease

The previous edition focused in particular on these issues:

Journal of Clinical Oncology primarily tackles Internal medicine, Oncology, Cancer research, In patient and Cancer. The journal tackles issues in Internal medicine, particularly in the topics of Chemotherapy, Breast cancer, Colorectal cancer, Prostate cancer and Lung cancer. More specifically, the research on Lung cancer in Journal of Clinical Oncology is related to Non small cell.

In addition to Oncology research, it aims to explore topics under Pembrolizumab, Nivolumab, Immunotherapy and Phases of clinical research. Some problems in Cancer research that were presented in Journal of Clinical Oncology overlapped with concepts under Gene and Immune checkpoint inhibitors. Concepts in Coronavirus disease 2019 (COVID-19), as well as related topics in 2019-20 coronavirus outbreak, are covered in the Cancer research presented in the journal.

The most cited articles from the last journal are:

  • IMbrave150: Updated overall survival (OS) data from a global, randomized, open-label phase III study of atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC). (63 citations)
  • Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study. (62 citations)
  • Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma. (47 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Journal of Clinical Oncology (based on the number of publications) are:

  • Hagop M. Kantarjian (516 papers) published 14 papers at the last edition, 5 more than at the previous edition,
  • Toni K. Choueiri (471 papers) published 46 papers at the last edition, 1 more than at the previous edition,
  • Heinz-Josef Lenz (376 papers) published 27 papers at the last edition, 1 less than at the previous edition,
  • Robert J. Motzer (367 papers) published 25 papers at the last edition the same number as at the previous edition,
  • Gabriel N. Hortobagyi (353 papers) published 3 papers at the last edition, 5 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Clinical Oncology (based on the number of publications) are:

  • Harvard University (6429 papers) published 643 papers at the last edition, 52 less than at the previous edition,
  • University of Texas MD Anderson Cancer Center (6250 papers) published 550 papers at the last edition, 77 less than at the previous edition,
  • Memorial Sloan Kettering Cancer Center (5058 papers) published 462 papers at the last edition, 33 less than at the previous edition,
  • Mayo Clinic (3100 papers) published 289 papers at the last edition, 52 less than at the previous edition,
  • University of California, San Francisco (1933 papers) published 226 papers at the last edition, 19 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 9.20% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 32.91% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.86% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.50% of all publications and 42.72% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Oncology

Many aspiring healthcare professionals may wonder how they can contribute to the essential field of Oncology after reading about the diverse research topics and work in the Journal of Clinical Oncology. Numerous professions within healthcare allow professionals to be actively involved in this vital area. One such profession is a Nurse Practitioner specialized in Oncology.

A Nurse Practitioner (NP) is a registered nurse (RN) who, in addition to their RN training, has completed a master's degree in nursing (MSN) and obtained state licensing. Oncology Nurse Practitioners have specialized education and training in cancer care, which often involves managing the symptoms and side effects of cancer treatments. They play a pivotal role in healthcare teams, often working alongside Oncologists to ensure the overall well-being of their patients.

If you are intrigued by the medical advancements covered in the Journal of Clinical Oncology and feel inspired to make a career shift, you may want to consider becoming a Nurse Practitioner with a focus on Oncology. You can read more about how to embark on this journey at this link how to be a nurse practitioner in Nevada.

It's noteworthy to remember that medical professions, including NP, require individuals to stay current with the latest advancements in their field. Therefore, it could be valuable to follow the research trends and most cited papers in the Journal of Clinical Oncology for aspirational and current healthcare professionals.

Top Publications

  • Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.

    Aurelien Marabelle;Dung T. Le;Paolo A. Ascierto;Anna Maria Di Giacomo

    (2020)
    2816 Citations
  • Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

    (2023)
    2583 Citations
  • FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

    (2023)
    1595 Citations
  • Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial

    Richard S. Finn;Baek-Yeol Ryoo;Philippe Merle;Masatoshi Kudo

    (2020)
    1469 Citations
  • Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

    (2023)
    1335 Citations
  • Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

    Nigel S Key;Alok A Khorana;Nicole M Kuderer;Kari Bohlke

    (2020)
    1238 Citations
  • Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684

    (2023)
    1127 Citations
  • Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

    (2022)
    1102 Citations
  • Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.

    Kimberly H. Allison;M. Elizabeth H. Hammond;Mitchell Dowsett;Shannon E. McKernin

    (2020)
    981 Citations
  • Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial.

    David A. Palma;Robert Olson;Stephen Harrow;Stewart Gaede

    (2020)
    967 Citations

Related Online Degrees & Career Pathways

For those interested in the medical field but exploring alternatives to becoming a physician, numerous online degrees and certifications offer promising career pathways. One option is pursuing a career in medical billing and coding. Understanding whether is medical coding a good career can help you determine if this role matches your skills and professional goals. It offers the chance to work behind the scenes in healthcare administration, with steady demand and flexible job options.

If you are interested in management roles within healthcare, consider looking into health information management online programs. These programs teach critical skills in managing patient data, regulatory compliance, and healthcare technology — all vital to modern medical facilities.

For those passionate about nutrition and wellness, an online master's degree in nutrition provides advanced knowledge and credentials needed for specialized roles in dietetics, public health, or research. Such degrees expand career prospects beyond clinical practice into consultancy and educational services.

Additionally, if you prefer hands-on technical work, consider certification as an ultrasound technician. Many reputable ultrasound tech certification online programs are designed to offer flexible learning alongside practical training, preparing you for a critical diagnostic role in healthcare settings.

Best Scientists Contributing to This Journal

Recently Published Articles